Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/dinto_DB00073
http://purl.obolibrary.org/obo/dinto_DB00073
|
|---|---|
| Preferred Name | rituximab |
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | rituximab
|
|---|---|
| label | rituximab
|
| DBSynonym |
anticd20
ig gamma-1 chain c region
|
| ATCCode | L01XC02
|
| Definition | Rituxan is a genetically engineered chimeric murine/human monoclonal antibody directed against the CD20 antigen found on the surface of normal and malignant B lymphocytes. The antibody is an IgG1 kappa immunoglobulin containing murine light- and heavy-chain variable region sequences and human constant region sequences. Rituximab is composed of two heavy chains of 451 amino acids and two light chains of 213 amino acids
|
| has pharmacological target | |
| type | |
| AHFScode | 10:00.00
|
| xref |
Wikipedia:http://en.wikipedia.org/wiki/Rituximab
GenBank:J00228
National Drug Code Directory:50242-053-06
Drugs.com:http://www.drugs.com/cdi/rituximab.html
Drugs Product Database (DPD):2241927
PharmGKB:PA451261
UniProtKB:P01857
RxList:http://www.rxlist.com/cgi/generic/ritux.htm
See more
See less
|
| CASRN | 174722-31-7
|
| prefixIRI | obo2:dinto_DB00073
|
| related with |
See more
See less
|
| may interact with |
See more
See less
|
| DBBrand |
rituxan
mabthera
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |